Glenmede Trust’s Zai Lab ZLAB Stock Holding History

Glenmede Trust’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-347	Closed	-$28K	–	2292
2020 Q3	$28K	Buy	347 +119	+52%	+$9.55K	﹤0.01%	1488
2020 Q2	$18K	Buy	+228	New	+$15.4K	﹤0.01%	1639

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Glenmede Trust's ZLAB Position: Q4 2020 in Review

Glenmede Trust sold out of Zai Lab (ZLAB) in Q4 2020, closing a stake of 347 shares — an estimated $28K sold.

Glenmede Trust first reported a position in ZLAB in Q2 2020 and held it in 2 quarters. The position peaked at $28K in Q3 2020. 191 funds tracked by Wall St. Rank hold ZLAB as of Q4 2020.

Glenmede Trust reported no remaining Zai Lab position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 347 Zai Lab shares in Q4 2020, an estimated $28K.
Glenmede Trust first reported a position in Zai Lab in Q2 2020 and held it in 2 quarters.
Glenmede Trust's Zai Lab position peaked at $28K in Q3 2020.
191 funds tracked by Wall St. Rank held Zai Lab as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.